Darel Martinez Bedoya (@darelmb) header
Darel Martinez Bedoya (@darelmb) profile picture
Lausanne, Switzerland
Joined February 2018
Photo by Darel Martinez Bedoya (@darelmb)
Darel Martinez Bedoya retweeted
🚨 NEW: One of the largest COVID-19 vaccine studies ever (28 MILLION people in France) just dropped. Results? • 74% lower risk of death from severe COVID-19 • 25% lower risk of all-cause mortality • No increase in 4-year mortality • Vaccinated people had lower risk of death from any cause. In short: mRNA vaccines weren’t just safe — they were protective across the board. 🔥📉
4
8,166
1,046
38,767
10,191,976
Darel Martinez Bedoya retweeted
5 breakthroughs in medicine this week 1. A lasting cure for severe combined immunodeficiency (SCID) SCID used to be called “bubble boy disease”, because patients had to live inside sterile plastic bubbles to avoid infection These are long-term (up to 11 year) follow-up results for patients treated with gene-corrected autologous haematopoietic stem cell transplants Survival was 100%: this is a curative therapy for a condition whose life expectancy used to be <2 years nejm.org/doi/full/10.1056/NE…
3
75
8
400
39,566
Darel Martinez Bedoya retweeted
This might be the most disturbing AI paper of 2025 ☠️ Scientists just proved that large language models can literally rot their own brains the same way humans get brain rot from scrolling junk content online. They fed models months of viral Twitter data short, high-engagement posts and watched their cognition collapse: - Reasoning fell by 23% - Long-context memory dropped 30% - Personality tests showed spikes in narcissism & psychopathy And get this even after retraining on clean, high-quality data, the damage didn’t fully heal. The representational “rot” persisted. It’s not just bad data → bad output. It’s bad data → permanent cognitive drift. The AI equivalent of doomscrolling is real. And it’s already happening. Full study: llm-brain-rot. github. io
620
5,325
1,137
27,905
2,813,959
🔥 1/ A new Nature Biotech paper from MIT might quietly redefine dose control in gene therapy. It introduces something called DIAL promoters, where you literally edit dose into DNA itself. No re-dosing. No chronic drugs. Just one genetic dial. Here’s why that’s huge for AAV, CAR-T, and cell therapy 🧵👇🏼
🤖 Made with AI
2
23
1
135
12,335
Darel Martinez Bedoya retweeted
This is 💯 correct. Nature Medicine study analysed 100 million US health records, found shingles vaccines reduces dementia 17-33% over 3-5 years, and more recent UK/Welsh data show 20% dementia reduction from shingles shots. Agree with Eric, don’t wait until 50.
🧠DEMENTIA PREVENTION—Almost everyone needs to go out now and get the shingles vaccine ASAP. Don’t wait until age 50 for standard eligibility—ask your doctor for singles vax. MULTIPLE large studies worldwide now show that shingles vaccine strongly prevents dementia onset. Do it.
61
374
16
1,843
106,510
Darel Martinez Bedoya retweeted
"Only ~0.02%-3.1% of [a cell's] genome" is being transcribed at any given moment. Other interesting takeaways from this new paper: > If you pool together a bunch of cells of the SAME type (like primary immune cells from a mouse's spleen), and you measure the transcription for each of them, you'll find that ~67% of the genome is active collectively. But at a SINGLE cell level, only like 0.04% of the genome is active. There is huge heterogeneity between cells, even of the same type. This heterogeneity disappears when we do bulk RNA-seq and measure cells together. > About 31% of a cell's transcription comes from known protein-coding genes. The rest of transcription happens in regions that don't make proteins. In other words, more "non-coding" DNA is transcribed than "coding" DNA. > There is a surprising disconnect between RNA production & decay at the single-cell level. If you look at thousands of cells together, the rate of RNA production (how fast genes are transcribed) usually matches the rate of RNA decay (how fast old transcripts are degraded). This makes sense, because cells presumably would want to keep a fairly steady balance of RNA levels. But when scFLUENT-seq was used to look at individual cells, this "rule" broke down! For a given mRNA, some cells were making a lot of new copies even if old copies weren’t being degraded much, while other cells had the opposite. So transcription and decay don't seem to be tightly matched within a single cell at a given time after all. The balance between production + decay is only true in bulk.
16
174
19
909
159,543
Darel Martinez Bedoya retweeted
Huge shift in medicine! A therapy first built to fight cancer (CAR T-cells) just pushed a patient with drug-resistant ulcerative colitis into full remission. Reprogrammed immune cells could tackle not just cancer, but autoimmune diseases too.
19
683
38
2,560
330,043
Darel Martinez Bedoya retweeted
🧬 Science News: A new study hints at the possibility that Heart attacks may be caused by infections, not cholesterol. For decades, heart disease has been explained mainly by high cholesterol, hypertension, and lifestyle factors. But a new research suggests bacteria hidden inside artery may help trigger heart attacks. Scientists studying arterial plaques discovered biofilms, sticky bacterial colonies, that can remain dormant for years, safely hidden from both the immune system and antibiotics. When jolted awake by a viral infection or major stress, these bacteria appear to spark sudden inflammation, destabilizing the plaque and causing it to rupture. The result: a clot that can block blood flow and cause a heart attack. The study, published in the Journal of the American Heart Association, found genetic traces of oral bacteria inside the arteries of patients who died suddenly or underwent surgery for atherosclerosis. n some cases, researchers even observed bacteria breaking free from biofilms during heart attacks, while the immune system scrambled to respond. If confirmed, these findings could radically reshape how we understand—and treat—cardiovascular disease. New diagnostics, targeted antibiotics, or even vaccines might one day help prevent heart attacks by addressing infection risk, not just cholesterol levels. --- scitechdaily. com/heart-attacks-may-be-infectious-and-vaccines-could-prevent-them/
32
60
6
356
31,347
Darel Martinez Bedoya retweeted
Rubisco is (arguably) the most abundant protein on Earth. (LPP surely comes close, right?) It’s an enzyme that fixes CO₂ into sugars during photosynthesis. Unfortunately, as most people learn in school, Rubisco is inefficient. Sometimes it confuses O₂ for CO₂ and wastes energy. Plants make up for this in raw concentration; up to half the soluble protein in a leaf is Rubisco. People have been trying to engineer better Rubiscos for many decades, but it's not easy because the proteins are big, do not fold easily (they need chaperone proteins to help out), are made from 16 subunits in land plants. But there's a new paper in Nature Plants that looks really interesting. The TL;DR is that a group in Australia figured out how to express plant Rubiscos (and all SEVEN of their folding chaperones) using a set of 3 plasmids inside of E. coli cells. This enabled them to do "directed evolution" of Rubisco in bacterial cells, and quickly find Rubisco mutants that have higher enzymatic efficiency or that fold better. In addition to the 3 plasmids, the researchers also coaxed E. coli to make ribulose-1,5-biphosphate, or RuBP, which is the 5-carbon sugar that Rubisco smashes into carbon dioxide to make molecules of 3-PGA for central metabolism. Now, the clever bit is that you RANDOMLY MUTATE the three plasmids encoding the Rubisco to make millions of variants. Then, you transform those mutated plasmids into E. coli. If the E. coli do NOT make a functional Rubisco, RuBP levels build up and kill the cell; the molecule becomes toxic. But if the E. coli DO make a functional Rubisco, then they keep the RuBP levels in check and live just fine. Using this "screening assay," the researchers found 46 fast-growing colonies of E. coli. Two of those colonies encoded really useful mutations. One mutation (M116L) makes Rubisco about 25–40% faster. The other (A242V) makes it fold and assemble much more efficiently. They put this mutation into a "hybrid Arabidopsis–tobacco Rubisco," put that into tobacco plants, and measured growth. The plants with M116L grew 75% faster than wildtype. No guarantees this will scale to more useful crops, like wheat and corn and soybeans etc. But it seems like a nice in vitro assay for faster prototyping!
37
387
67
2,195
142,098
Darel Martinez Bedoya retweeted
#ScienceSaturday ❓ Could a vaccine help prevent relapse in KRAS-mutant colorectal cancer? ➡️ A new study in @Nature reports promising Phase 1 results for ELI-002 2P, an “off-the-shelf” KRAS vaccine. It works by directing vaccine peptides into lymph nodes, where they stimulate strong CD4⁺ and CD8⁺ T-cell responses. ➡️ In patients with minimal residual disease after surgery, those with robust T-cell responses had significantly longer relapse-free and overall survival. Some also cleared circulating tumor DNA, suggesting the vaccine helped eliminate lingering cancer cells. ➡️ Importantly, the immune response expanded beyond KRAS to other tumor mutations — a phenomenon called antigen spreading — which may enhance long-term control of cancer. 🌟 While larger trials are needed, this approach could open a new path for treating KRAS-driven colorectal and pancreatic cancers, where current immunotherapies often fall short. 🔗 Read more: nature.com/articles/s41591-0… @EileenMOReilly @MSKCancerCenter #CancerResearch #ColorectalCancer #CancerVaccine #CancerImmunotherapy
4
33
1
87
8,930
Darel Martinez Bedoya retweeted
No driver mutations could be identified in 181 tumors. The authors do not know why. Perhaps, it's an algorithmic failure. Perhaps, it reflects non genetic contributions to carcinogenesis. What do you think ?
49
101
15
724
93,952
Darel Martinez Bedoya retweeted
Nearly one-third of all retracted papers at PLoS ONE can be traced back to just 45 researchers who served as editors at the journal go.nature.com/47dYCTx
9
87
11
230
34,075
Darel Martinez Bedoya retweeted
Preprint: TCR-enriched nanoscale vesicles shed by activated T cells (ectosomes) are transferred to antigen-primed B cells, where they engage and cluster cognate pMHCII, triggering signaling and specific IgG antibody production biorxiv.org/content/10.1101/…
1
24
2
99
6,188
Darel Martinez Bedoya retweeted
Review @JCI_insight Enhancing the potency of CAR-T cells against solid tumors through transcription factor engineering insight.jci.org/articles/vie…
17
62
3,381
Darel Martinez Bedoya retweeted
🚨New paper on theories of ageing I discuss the major mechanistic theories of ageing in light of recent findings as well as the fundamental nature of the ageing process. Theoretical work is more important than ever in biology, including in ageing. nature.com/articles/s41556-0…
34
96
10
425
54,904